Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Edwards Lifesciences
The study is a multi-center, prospective single arm study designed to evaluate the safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Functional or degenerative TR moderate or greater
Symptomatic despite medical therapy or prior HF hospitalization from TR
The Local Site Heart Team determines that the patient is appropriate for transcatheter tricuspid valve replacement
You may not be if
Tricuspid valve anatomic contraindications
Need for emergent or urgent surgery or any planned cardiac surgery within the next 12 months
